AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2020
Aug 12, 2020
34931_dirs_2020-08-12_433ec463-2de9-4d68-8655-4307b6c90661.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2020-07-28
Reporting Person: Davidson Michael H. (Director)